drugset

drugset / Trial / NCT06749795

LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC)

NCT06749795 ↗

Phase 1 Not yet recruiting 15 enrolled Liveome Inc.

RandomizedParallel-groupTriple-blindTreatment

Summary

A Phase 1b study to evaluate the safety and tolerability of LIV001 in Patients with Mild-to- Moderate Active Ulcerative Colitis

Timeline

Start: 2025-03-24
Primary completion: 2026-01-17
Completion: 2026-03-24

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	LIV001	Unknown	—	Oral

Indications